ArticleCancers2024

Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma.

Anna Tutusaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.